Sinigaglia Francesco

Sinigaglia Francesco is an accomplished entrepreneur and investor with extensive experience in the biotechnology sector. Since March 2012, Sinigaglia has been self-employed while also serving as a Senior Advisor and a member of the Executive Board for Italian Angels for Biotech IAB since September 2015. Notably, Sinigaglia co-founded Anabasis Pharma in 2009 and held the positions of Co-Founder and Executive Director until its sale to Dompé in February 2012. Previous roles include Chairman at Eyevensys, a member of the board of directors at Okairos, and CEO, Co-Founder, and Managing Director at Bioxell SpA. Sinigaglia's career began at Roche, where significant contributions were made as Research Director. Academic qualifications include a medical degree from Università degli Studi di Padova, followed by post-graduate studies in Pharmacology and Immunology at Università degli Studi di Milano and UCL.